Market Capitalization of Alembic Pharmaceuticals (APLLTD)
As of Aug. 21, 2026, Alembic Pharmaceuticals (APLLTD) market capitalisation is ₹16166.33 Cr ($1.80B), with 19.67 Cr shares outstanding at a current price of ₹821.75 on NSE, ranking 433 out of 5355 companies by market cap in our screener. Alembic Pharmaceuticals operates in the Healthcare sector and is classified as a Mid Cap stock. For live price, earnings and the complete company profile, see APLLTD share price screener.
Market Cap History of Alembic Pharmaceuticals (Last 10 Years)
APLLTD market capitalisation from year-end NSE closing prices over the last 10 years. Browse APLLTD financial statements for revenue, profit, balance sheet and cash flow data.
End of Year Market Cap History — Alembic Pharmaceuticals
APLLTD year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. Examine APLLTD quarterly performance for recent quarterly revenue, profit and EPS trends.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹16166.33 Cr
$1.80B USD
|
₹821.75 | NSE | -2.88% |
| 2025 |
₹16646.35 Cr
$1.85B USD
|
₹846.15 | NSE | -20.64% |
| 2024 |
₹20976.39 Cr
$2.33B USD
|
₹1066.25 | NSE | +40.41% |
| 2023 |
₹14939.72 Cr
$1.66B USD
|
₹759.40 | NSE | +32.55% |
| 2022 |
₹11270.69 Cr
$1.25B USD
|
₹572.90 | NSE | -28.56% |
| 2021 |
₹15775.82 Cr
$1.75B USD
|
₹801.90 | NSE | -22.43% |
| 2020 |
₹20337.02 Cr
$2.26B USD
|
₹1033.75 | NSE | +80.95% |
| 2019 |
₹11239.21 Cr
$1.25B USD
|
₹571.30 | NSE | -4.74% |
| 2018 |
₹11797.93 Cr
$1.31B USD
|
₹599.70 | NSE | +13.02% |
| 2017 |
₹10438.52 Cr
$1.16B USD
|
₹530.60 | NSE | -10.84% |
| 2016 |
₹11707.43 Cr
$1.30B USD
|
₹595.10 | NSE | -14.50% |
| 2015 |
₹13693.43 Cr
$1.52B USD
|
₹696.05 | NSE | +56.36% |
| 2014 |
₹8757.46 Cr
$973.05M USD
|
₹445.15 | NSE | +110.87% |
| 2013 |
₹4152.98 Cr
$461.44M USD
|
₹211.10 | NSE | +191.17% |
| 2012 |
₹1426.30 Cr
$158.48M USD
|
₹72.50 | NSE | +104.51% |
| 2011 |
₹697.41 Cr
$77.49M USD
|
₹35.45 | NSE | - |